# Theophylline

NDC: 71321-501
Generic name: Theophylline
Labeler / Manufacturer: Brandywine Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250930

FDA application: ANDA087400

## Active ingredients

- THEOPHYLLINE ANHYDROUS: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71321-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71321-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b98b47d-0a6e-4621-b047-bdb8bcef4836
